Chemotherapy of advanced transitional cell carcinoma of the renal pelvis: report of 3 cases treated with vinblastine and chloroethyl-cyclohexyl-nitrosourea.

Abstract	Three patients with advanced transitional cell carcinoma of the renal pelvis were treated with 5 mg./m.2 body surface vinblastine intravenously weekly and 130 mg./m.2 chloroethyl-cyclohexyl-nitrosourea orally with 6-week intervals. One patient had a partial remission for 1.5 months and 2 had stationary disease for 6 and 2 months.
Authors	F von Eyben, W Mattsson, I Glifberg, C E Lindholm
Journal	The Journal of urology (J Urol) Vol. 121 Issue 3 Pg. 367-8 (Mar 1979) ISSN: 0022-5347 [Print] United States
PMID	430637 (Publication Type: Case Reports, Journal Article)
Chemical References	Nitrosourea Compounds Vinblastine Lomustine
Topics	Carcinoma, Transitional Cell (drug therapy) Drug Therapy, Combination Female Humans Kidney Neoplasms (drug therapy) Kidney Pelvis Lomustine (therapeutic use) Male Middle Aged Nitrosourea Compounds (therapeutic use) Vinblastine (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!